Publicaciones en las que colabora con Jesús Rodríguez-Baño (15)

2024

  1. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

2021

  1. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

    BMC Infectious Diseases, Vol. 21, Núm. 1

2020

  1. Outcomes of the PIRASOA programme, an antimicrobial stewardship programme implemented in hospitals of the Public Health System of Andalusia, Spain: an ecologic study of time-trend analysis

    Clinical Microbiology and Infection, Vol. 26, Núm. 3, pp. 358-365

2018

  1. Unsolicited consultation by infectious diseases specialist improves outcomes in patients with bloodstream infection: A prospective cohort study

    Journal of Infection, Vol. 77, Núm. 6, pp. 503-508

2016

  1. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain

    Journal of Infection, Vol. 72, Núm. 2, pp. 152-160

2014

  1. Are hip hemiarthroplasty and total hip arthroplasty infections different entities? The importance of hip fractures

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 33, Núm. 8, pp. 1439-1448

  2. La amenaza de las enterobacterias productoras de carbapenemasas en España: Documento de posicionamiento de los grupos de estudio GEIH y GEMARA de la SEIMC

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 10, pp. 666-670

  3. Predictors of early mortality in very elderly patients with bacteremia: A prospective multicenter cohort

    International Journal of Infectious Diseases, Vol. 26, pp. 83-87

2013

  1. Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: A prospective cohort study

    BMC Infectious Diseases, Vol. 13, Núm. 1

2012

  1. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: A propensity score-based analysis

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 1, pp. 472-478

  2. Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH

    Farmacia Hospitalaria, Vol. 36, Núm. 1

  3. Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 1

2011

  1. Candidemias: Análisis multicéntrico en 16 hospitales andaluces

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 5, pp. 328-333

  2. Programs to optimize antimicrobial use (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document

    Medicina Preventiva, Vol. 17, Núm. 3, pp. 29-39

2010

  1. Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals

    Clinical Microbiology and Infection, Vol. 16, Núm. 9, pp. 1408-1413